Silo Pharma (NASDAQ:SILO – Get Rating) and Li Ning (OTCMKTS:LNNGY – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.
Analyst Ratings
This is a summary of current ratings and price targets for Silo Pharma and Li Ning, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Silo Pharma | 0 | 0 | 0 | 0 | N/A |
Li Ning | 0 | 0 | 1 | 0 | 3.00 |
Profitability
Net Margins | Return on Equity | Return on Assets | |
Silo Pharma | -4,622.68% | -35.46% | -31.26% |
Li Ning | N/A | N/A | N/A |
Earnings and Valuation
This table compares Silo Pharma and Li Ning’s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Silo Pharma | $70,000.00 | 85.23 | $3.90 million | N/A | N/A |
Li Ning | $3.50 billion | 5.44 | $621.69 million | N/A | N/A |
Li Ning has higher revenue and earnings than Silo Pharma.
Institutional & Insider Ownership
11.6% of Silo Pharma shares are owned by institutional investors. Comparatively, 0.0% of Li Ning shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Li Ning beats Silo Pharma on 6 of the 8 factors compared between the two stocks.
About Silo Pharma
Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in merging traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. The company was founded by Eric Weisblum on July 13, 2010 and is headquartered in Englewood Cliffs, NJ.
About Li Ning
Li Ning Co., Ltd. engages in the provision of sporting goods. The company focuses on the research and development, design, manufacture, distribution, and retail of products including footwear, apparel, equipment, and accessories for professional and leisure purposes. It operates through the LI-NING Brand and All Other Brands segments. The company was founded by Ning Li in 1989 and is headquartered in Beijing, China.
Receive News & Ratings for Silo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.